NASDAQ:AMEH Apollo Medical (AMEH) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free AMEH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$40.71▼$42.7550-Day Range$35.30▼$41.7052-Week Range$28.86▼$43.12Volume313,900 shsAverage Volume166,711 shsMarket Capitalization$2.38 billionP/E Ratio40.82Dividend YieldN/APrice Target$47.20 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Get Apollo Medical alerts: Email Address Apollo Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside15.6% Upside$47.20 Price TargetShort InterestN/ADividend StrengthN/ASustainability-0.69Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth32.50%From $1.20 to $1.59 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.02 out of 5 starsMedical Sector412th out of 908 stocksManagement Consulting Services Industry12th out of 16 stocks 2.4 Analyst's Opinion Consensus RatingApollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageApollo Medical has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AMEH. Previous Next 0.0 Dividend Strength Dividend YieldApollo Medical does not currently pay a dividend.Dividend GrowthApollo Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.Environmental SustainabilityThe Environmental Impact score for Apollo Medical is -0.69. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Apollo Medical this week, compared to 1 article on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apollo Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Apollo Medical is held by insiders.Percentage Held by InstitutionsOnly 35.88% of the stock of Apollo Medical is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Apollo Medical are expected to grow by 32.50% in the coming year, from $1.20 to $1.59 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.69.Price to Earnings Ratio vs. SectorThe P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 227.84.Price to Earnings Growth RatioApollo Medical has a PEG Ratio of 1.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioApollo Medical has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Apollo Medical Stock (NASDAQ:AMEH)Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. AMEH Stock News HeadlinesApril 26, 2024 | reuters.comIndia's Apollo Hospitals' unit to raise $297 mln from PE firm AdventApril 12, 2024 | forbes.comApollo Wearable Review — Better Sleep Is PossibleApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 7, 2024 | msn.comApollo Spectra and Apollo One launch Boutique Healthcare Hub; To focus on elective procedures and preventive healthcareMarch 19, 2024 | yahoo.comApollo Returns & More Must-See Moments from Married to Med's Season 10 Reunion FinaleFebruary 29, 2024 | finance.yahoo.comAstrana Health Full Year 2023 Earnings: EPS Beats ExpectationsFebruary 27, 2024 | finance.yahoo.comAstrana Health Inc (ASTH) Reports Growth in Revenue and Net Income for Q4 and Full Year 2023February 27, 2024 | msn.comJefferies Initiates Coverage of Apollo Medical Holdings (AMEH) with Buy RecommendationApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 26, 2024 | investorplace.comThe 3 Most Popular Stocks Owned by Congress in Q1February 26, 2024 | markets.businessinsider.comApollo Medical earnings preview: what Wall Street is expectingFebruary 23, 2024 | msn.comB of A Securities Upgrades Apollo Medical Holdings (AMEH)February 22, 2024 | msn.comApollo Medical to change name to Astrana HealthFebruary 22, 2024 | msn.comApollo Medical upgraded to buy at BoA on revenue, earnings growthFebruary 22, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. Becomes Astrana Health, Inc.February 22, 2024 | prnewswire.comApollo Medical Holdings, Inc. Becomes Astrana Health, Inc.February 20, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings GrowthFebruary 15, 2024 | finance.yahoo.comAMEH May 2024 30.000 callFebruary 15, 2024 | finance.yahoo.comAMEH May 2024 25.000 putFebruary 15, 2024 | wsj.comApollo Medical Holdings Inc.February 14, 2024 | msn.comApollo Health moves to Oracle Fusion Cloud ERP for managing financial operationsFebruary 8, 2024 | msn.comApollo PAT up 60% on robust growth across businessesFebruary 8, 2024 | investing.comApollo Medical Holdings Inc (AMEH)February 8, 2024 | msn.comApollo Hospitals Q3 Results: Net profit rises 60% to Rs 245 croreFebruary 8, 2024 | finance.yahoo.comAn excellent week for Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) institutional owners who own 47% as one-year returns inch higherJanuary 31, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference CallJanuary 30, 2024 | msn.comApolloMed and BASS partner to enhance value-based healthcareSee More Headlines Receive AMEH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today4/26/2024Next Earnings (Estimated)5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryN/A Current SymbolNASDAQ:AMEH CUSIPN/A CIK1083446 Webwww.apollomed.net Phone(626) 282-0288Fax818-839-5190Employees1,362Year FoundedN/APrice Target and Rating Average Stock Price Target$47.20 High Stock Price Target$55.00 Low Stock Price Target$41.00 Potential Upside/Downside+15.6%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio40.82 Forward P/E Ratio34.02 P/E Growth1.15Net Income$45.17 million Net Margins3.56% Pretax Margin7.48% Return on Equity9.90% Return on Assets5.51% Debt Debt-to-Equity Ratio0.35 Current Ratio2.35 Quick Ratio2.35 Sales & Book Value Annual Sales$1.14 billion Price / Sales2.08 Cash Flow$1.26 per share Price / Cash Flow32.51 Book Value$9.60 per share Price / Book4.25Miscellaneous Outstanding Shares58,280,000Free Float53,353,000Market Cap$2.38 billion OptionableOptionable Beta1.04 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Kenneth T. Sim M.D. (Age 70)Executive Chairman Comp: $1.49MMr. Brandon Sim (Age 29)President & CEO Comp: $1.73MMr. Chandan Basho (Age 41)CFO & COO Comp: $581.42kDr. WaiChow Young M.D. (Age 77)Chief Administrative Officer Comp: $573.67kMr. John Vong (Age 51)Chief Accounting Officer Dr. Jeremy R. Jackson M.D.Chief Quality OfficerMr. Neil AhujaPresident of Provider SolutionsYubin ParkChief Data & Analytics OfficerDr. Carlos Palacios M.D.Chief Medical Officer for TexasDr. Dinesh M. Kumar M.D. (Age 55)Chief Medical Officer More ExecutivesKey CompetitorsICF InternationalNASDAQ:ICFIAstrana HealthNASDAQ:ASTHICU MedicalNASDAQ:ICUICorcept TherapeuticsNASDAQ:CORTMerusNASDAQ:MRUSView All CompetitorsInstitutional OwnershipState of Alaska Department of RevenueSold 618 shares on 4/19/2024Ownership: 0.044%Vanguard Group Inc.Bought 260,687 shares on 3/11/2024Ownership: 8.665%Campbell & CO Investment Adviser LLCBought 27,849 shares on 2/13/2024Ownership: 0.048%D.A. Davidson & CO.Sold 1,734 shares on 2/9/2024Ownership: 0.048%Quest Partners LLCBought 2,699 shares on 2/9/2024Ownership: 0.005%View All Institutional Transactions AMEH Stock Analysis - Frequently Asked Questions Should I buy or sell Apollo Medical stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares. View AMEH analyst ratings or view top-rated stocks. What is Apollo Medical's stock price target for 2024? 5 Wall Street research analysts have issued twelve-month price targets for Apollo Medical's stock. Their AMEH share price targets range from $41.00 to $55.00. On average, they anticipate the company's share price to reach $47.20 in the next twelve months. This suggests a possible upside of 15.6% from the stock's current price. View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts. When is Apollo Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our AMEH earnings forecast. How were Apollo Medical's earnings last quarter? Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its quarterly earnings results on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 9.90% and a net margin of 3.56%. During the same period last year, the business earned $0.45 EPS. What guidance has Apollo Medical issued on next quarter's earnings? Apollo Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of 1.100-1.200 for the period, compared to the consensus estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. What is Thomas Lam's approval rating as Apollo Medical's CEO? 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend. What other stocks do shareholders of Apollo Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM). Who are Apollo Medical's major shareholders? Apollo Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.04%). Insiders that own company stock include Albert Waichow Young, Brandon Sim, Linda Marsh and Physicians Of Californi Allied. View institutional ownership trends. Does Apollo Medical have any subsidiaries? The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..Read More This page (NASDAQ:AMEH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollo Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.